Belzutifan
Belzutifan is a pharmaceutical raw material that acts as an inhibitor of hypoxia-inducible factor 2α (HIF-2α). It is used in research and manufacturing related to certain cancer pathways, particularly those associated with von Hippel-Lindau disease.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1672668-24-4
Exo-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl diphenylglycolate hydrochloride
active pharmaceutical ingredient
Ornidazole
Active pharmaceutical ingredient
Desmopressin diacetate
active pharmaceutical ingredient
Flibanserin
active pharmaceutical ingredient
HIF-2alpha-IN-2
HIF-2alpha inhibitor research compound
(Rac)-PT2399
Research compound for hypoxia-inducible factor
3-[[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]oxy]-5-fluorobenzonitrile
LOMMPXLFBTZENJ-ZACQAIPSSA-N
CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O